1. Home
  2. MEGL vs SONN Comparison

MEGL vs SONN Comparison

Compare MEGL & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEGL
  • SONN
  • Stock Information
  • Founded
  • MEGL 2016
  • SONN N/A
  • Country
  • MEGL Hong Kong
  • SONN United States
  • Employees
  • MEGL N/A
  • SONN N/A
  • Industry
  • MEGL Finance: Consumer Services
  • SONN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEGL Finance
  • SONN Health Care
  • Exchange
  • MEGL Nasdaq
  • SONN Nasdaq
  • Market Cap
  • MEGL 6.8M
  • SONN 3.8M
  • IPO Year
  • MEGL 2022
  • SONN N/A
  • Fundamental
  • Price
  • MEGL $1.38
  • SONN $3.47
  • Analyst Decision
  • MEGL
  • SONN Strong Buy
  • Analyst Count
  • MEGL 0
  • SONN 1
  • Target Price
  • MEGL N/A
  • SONN $20.00
  • AVG Volume (30 Days)
  • MEGL 36.3K
  • SONN 726.3K
  • Earning Date
  • MEGL 09-02-2025
  • SONN 08-13-2025
  • Dividend Yield
  • MEGL N/A
  • SONN N/A
  • EPS Growth
  • MEGL N/A
  • SONN N/A
  • EPS
  • MEGL N/A
  • SONN N/A
  • Revenue
  • MEGL $1,645,862.00
  • SONN $1,000,000.00
  • Revenue This Year
  • MEGL N/A
  • SONN $5,376.22
  • Revenue Next Year
  • MEGL N/A
  • SONN N/A
  • P/E Ratio
  • MEGL N/A
  • SONN N/A
  • Revenue Growth
  • MEGL N/A
  • SONN 1689.52
  • 52 Week Low
  • MEGL $1.02
  • SONN $1.08
  • 52 Week High
  • MEGL $5.52
  • SONN $19.30
  • Technical
  • Relative Strength Index (RSI)
  • MEGL 43.82
  • SONN 49.02
  • Support Level
  • MEGL $1.33
  • SONN $2.99
  • Resistance Level
  • MEGL $1.40
  • SONN $3.61
  • Average True Range (ATR)
  • MEGL 0.06
  • SONN 0.48
  • MACD
  • MEGL 0.00
  • SONN 0.01
  • Stochastic Oscillator
  • MEGL 34.78
  • SONN 54.70

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Share on Social Networks: